Lovastatin, a drug used in the treatment of hypercholesterolemia was reported previously to exert synergistic antitumor activity in mice, when used together with tumor necrosis factor-α (TNF-α). As interferon-γ (IFN-γ) was also demonstrated previously to synergistically potentiate antitumor activity of TNF-α, we decided to use lovastin together with TNF-α and IFN-γ in treatment of melanoma MmB 16. Statistically significant inhibition of tumor growth was observed in mice treated with combination of all these agents in comparison to each of the remaining experimental groups. The results of this study extend the previous findings of synergistic efficacy of lovastatin and TNF-α and suggest that the effectiveness of local treatment may be augmented by the use of two or more synergistically acting agents in murine tumor models.
|Original language||English (US)|
|Number of pages||4|
|Journal||Central-European Journal of Immunology|
|State||Published - 1996|
ASJC Scopus subject areas